Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M—which ...
Sep 11, 2022
0
5
According to a new modeling study, published in JAMA Pediatrics, the number of children estimated to have experienced the death of a parent or caregiver as a result of the COVID-19 pandemic has climbed to more than 10.5 million ...
Sep 7, 2022
0
66
A new study, led by researchers at the University of Oxford, UK, in collaboration with the University of California, Berkeley, U.S., published today in Lancet Diabetes & Endocrinology identifies, as early as the fifth month ...
Aug 25, 2022
0
83
COVID-19 affected life expectancy around the world. In the U.S. life expectancy losses were much larger for Hispanic and Black males in the U.S. compared with their White counterparts, according to new research published ...
Aug 25, 2022
0
17
Researchers at NDORMS have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.
Aug 22, 2022
0
63
A new study published in The Lancet Psychiatry from the University of Oxford and the National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre investigated neurological and psychiatric ...
Aug 17, 2022
0
100
Understanding which cells give rise to which areas of cancer can improve our understanding of how a tumor has grown and developed, including how it has changed genetically over time. This has been made possible using a new ...
Aug 10, 2022
0
41
Clinical researchers from Oxford University's Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients ...
Aug 8, 2022
0
10
A revolutionary new hand prosthesis powered and controlled by the user's breathing has been developed by researchers at the University of Oxford.
Jul 29, 2022
0
3
Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the immune response and safety of their newly-developed single shot rabies vaccine, ChAdOx2 RabG—with promising ...
Jul 28, 2022
0
101
